7-50402906-T-G
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006060.6(IKZF1):c.*2279T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.241 in 228,706 control chromosomes in the GnomAD database, including 7,068 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (★).
Frequency
Consequence
NM_006060.6 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- pancytopenia due to IKZF1 mutationsInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- autoimmune diseaseInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006060.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IKZF1 | NM_006060.6 | MANE Select | c.*2279T>G | 3_prime_UTR | Exon 8 of 8 | NP_006051.1 | |||
| IKZF1 | NM_001410879.1 | c.*2279T>G | 3_prime_UTR | Exon 9 of 9 | NP_001397808.1 | ||||
| IKZF1 | NM_001220765.3 | c.*2279T>G | 3_prime_UTR | Exon 7 of 7 | NP_001207694.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| IKZF1 | ENST00000331340.8 | TSL:1 MANE Select | c.*2279T>G | 3_prime_UTR | Exon 8 of 8 | ENSP00000331614.3 | |||
| IKZF1 | ENST00000698577.1 | n.3074T>G | non_coding_transcript_exon | Exon 2 of 2 | |||||
| IKZF1 | ENST00000642219.2 | c.*2279T>G | 3_prime_UTR | Exon 8 of 8 | ENSP00000496655.2 |
Frequencies
GnomAD3 genomes AF: 0.246 AC: 37341AN: 152082Hom.: 4808 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.231 AC: 17709AN: 76506Hom.: 2255 Cov.: 0 AF XY: 0.230 AC XY: 8125AN XY: 35254 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.246 AC: 37368AN: 152200Hom.: 4813 Cov.: 33 AF XY: 0.249 AC XY: 18509AN XY: 74420 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Leukemia, acute lymphocytic, susceptibility to, 2 Other:1
In a genome wide association study of 2 case-control series, totaling 907 ALL cases and 2,398 controls, Papaemmanuil et al. (2009) found a significant association between ALL and a SNP at chromosome 7p12.2 in the IKZF1 gene (rs4132601, OR of 1.69, p = 1.20 x 10(-19)). The association was also highly significant when confined to B-cell ALL (OR of 1.73, p = 9.31 x 10(-20)). In vitro studies showed that IKZF1 mRNA expression was significantly associated with genotype in a dose-dependent fashion, with lower expression being associated with the C risk allele. The authors noted that Ikaros proteins are master regulators of lymphocyte development. By genotyping 1,384 cases of precursor B-cell childhood ALL and 1,877 controls from Germany and the United Kingdom, Prasad et al. (2010) found a significant association between IKZF1 SNP rs4132601 and ALL (OR of 1.69, p = 7.51 x 10(-22)). This finding replicated the susceptibility locus for ALL at chromosome 7p12.2 previously reported by Trevino et al. (2009) and Papaemmanuil et al. (2009).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at